Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Fate Therapeutics, Inc. (FATE)

« Back to company index

FATE Chatter Timeline

Stock Ticker for FATE

Most Active Tweeters for FATE

UserTweets
@MareaInformativ 10
@AmericanBanking 7
@ConsumerFeed 7
@confcalltran 6
@ThisLincolnian 6

Recent Tweets for FATE

ChartMill @ChartMill
Besides having an excellent technical rating, $FATE also presents a decent setup pattern. https://t.co/tH00tGbXFV https://t.co/GBVBmIHXEr
August 14th 2018, 8:08pm
MareaInformativ @MareaInformativ
Fate Therapeutics $FATE Announces Earnings Results, Misses Estimates By $0.05 EPS https://t.co/i4Un5C9XZB
August 14th 2018, 4:08pm
registrarjourn @registrarjourn
Fate Therapeutics $FATE Earns Outperform Rating from Wedbush https://t.co/TL3VV95pKo
August 14th 2018, 10:08am
MareaInformativ @MareaInformativ
Fate Therapeutics $FATE Raised to “Buy” at BidaskClub https://t.co/9LFZe82iHv
August 14th 2018, 7:08am
bbnsnews @bbnsnews
Fate Therapeutics $FATE Raised to “Buy” at BidaskClub https://t.co/bDGa39MWrB
August 14th 2018, 6:08am
TickerReport @TickerReport
Fate Therapeutics $FATE Raised to “Buy” at BidaskClub https://t.co/djdkaORpAP
August 14th 2018, 3:08am
MareaInformativ @MareaInformativ
Zacks Investment Research Lowers Fate Therapeutics $FATE to Sell https://t.co/yr6xZ4g42v
August 14th 2018, 1:08am
VistaPResearch @VistaPResearch
RT @VistaPResearch: Fate Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference August 14 $FATE $IBB #biotech #investing…
August 13th 2018, 3:08pm
VistaPResearch @VistaPResearch
Fate Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference August 14 $FATE $IBB #biotech… https://t.co/NaPawWsPYP
August 13th 2018, 2:08pm
WatchlistN @WatchlistN
Fate Therapeutics $FATE Rating Increased to Buy at BidaskClub https://t.co/ktPyJwDitA
August 13th 2018, 12:08pm
MareaInformativ @MareaInformativ
Fate Therapeutics Inc $FATE Expected to Post Quarterly Sales of $1.27 Million https://t.co/UM6AF0qwMj
August 13th 2018, 11:08am
EnterpriseLeade @EnterpriseLeade
Fate Therapeutics $FATE Lowered to “Hold” at BidaskClub https://t.co/LrhBvRYcw1
August 13th 2018, 6:08am
ChartMill @ChartMill
Looking at the yearly performance, $FATE did better than 98% of all other stocks. https://t.co/KA8AqYLfaC https://t.co/UE8X7tSfhK
August 12th 2018, 6:08pm
MareaInformativ @MareaInformativ
Brokerages Set Fate Therapeutics Inc $FATE Price Target at $16.17 https://t.co/WSeOR4J9bB
August 12th 2018, 2:08pm
ThisLincolnian @ThisLincolnian
BidaskClub Upgrades Fate Therapeutics $FATE to “Buy” https://t.co/4vhV7WpLv9
August 12th 2018, 4:08am
ConsumerFeed @ConsumerFeed
Q3 2018 EPS Estimates for Fate Therapeutics Inc Reduced by Wedbush $FATE https://t.co/2mokCrJO1l
August 12th 2018, 1:08am
ConsumerFeed @ConsumerFeed
Fate Therapeutics $FATE Upgraded to Buy at BidaskClub https://t.co/nOWIvbfQLZ
August 11th 2018, 5:08pm
TheMarketsDaily @TheMarketsDaily
Wedbush Reiterates Outperform Rating for Fate Therapeutics $FATE https://t.co/KRqqZFAQwN
August 11th 2018, 12:08pm
bbnsnews @bbnsnews
Q3 2018 Earnings Estimate for Fate Therapeutics Inc Issued By Wedbush $FATE https://t.co/aMEwvfacay
August 11th 2018, 6:08am
EnterpriseLeade @EnterpriseLeade
Somewhat Positive Press Coverage Somewhat Unlikely to Impact Fate Therapeutics $FATE Share Price https://t.co/5mQRQ36dDm
August 11th 2018, 4:08am
ThisLincolnian @ThisLincolnian
HC Wainwright Reiterates “Hold” Rating for Fate Therapeutics $FATE https://t.co/zLmldkIHuX
August 11th 2018, 4:08am
TheMarketsDaily @TheMarketsDaily
Fate Therapeutics $FATE Earns Hold Rating from HC Wainwright https://t.co/WcvPUU08OD
August 10th 2018, 5:08pm
TranscriptDaily @TranscriptDaily
Fate Therapeutics $FATE Earns Outperform Rating from Wedbush https://t.co/6jQeNiLYTy
August 10th 2018, 4:08pm
dispatchtribune @dispatchtribune
Fate Therapeutics $FATE Upgraded to “Hold” by Zacks Investment Research https://t.co/LpND7eEO4j
August 10th 2018, 12:08pm
dakotafinancial @dakotafinancial
Q3 2018 EPS Estimates for Fate Therapeutics Inc Reduced by Analyst $FATE https://t.co/TbKHtRpoUF
August 10th 2018, 7:08am
AmericanBanking @AmericanBanking
Q3 2018 EPS Estimates for Fate Therapeutics Inc Reduced by Analyst $FATE https://t.co/vxWKKZoH2q #stocks
August 10th 2018, 7:08am
bibeypost_stock @bibeypost_stock
Fate Therapeutics, Inc. $FATE has analysts on the Bullish side this week. - https://t.co/ybEgvBOljj
August 10th 2018, 7:08am
mmahotstuff1 @mmahotstuff1
Are Analysts Bearish Fate Therapeutics, Inc. $FATE After Last Week? - https://t.co/wlu6NTNoKS
August 10th 2018, 7:08am
reurope_stock @reurope_stock
Here's how analysts see Fate Therapeutics, Inc. $FATE after this past week. https://t.co/fXnzBJriQk
August 10th 2018, 7:08am
whatsonthorold2 @whatsonthorold2
This is what analysts have to say about Fate Therapeutics, Inc. $FATE after last week. - https://t.co/1mgaFydp4n
August 10th 2018, 7:08am
west_moreland @west_moreland
It's been a crucial week for Fate Therapeutics, Inc. $FATE; here's what analysts have to say. https://t.co/FOhNMtolQz
August 10th 2018, 7:08am
Fanob_stock @Fanob_stock
Discussion stirs around Fate Therapeutics, Inc. $FATE this week; here is what analysts are saying. https://t.co/uPMM4VfpfE
August 10th 2018, 7:08am
TranscriptDaily @TranscriptDaily
Fate Therapeutics $FATE Lifted to “Buy” at BidaskClub https://t.co/7H6DxwPmtY
August 10th 2018, 4:08am
WatchlistN @WatchlistN
Fate Therapeutics Inc $FATE Expected to Post Quarterly Sales of $1.57 Million https://t.co/0xWnKRlTtp
August 9th 2018, 6:08pm
ConsumerFeed @ConsumerFeed
Fate Therapeutics Inc $FATE Expected to Post Earnings of -$0.28 Per Share https://t.co/5OHuJ4i2y1
August 9th 2018, 6:08pm
ThisLincolnian @ThisLincolnian
Fate Therapeutics $FATE Raised to “Hold” at Zacks Investment Research https://t.co/3JaENe65x6
August 9th 2018, 4:08pm
dailypoliticaln @dailypoliticaln
Fate Therapeutics $FATE Stock Rating Reaffirmed by Wedbush https://t.co/3oVKTgDEBd
August 9th 2018, 4:08pm
WatchlistN @WatchlistN
Fate Therapeutics $FATE Stock Rating Reaffirmed by Wedbush https://t.co/eEtgyjhVm6
August 9th 2018, 4:08pm
AmericanBanking @AmericanBanking
Weekly Analysts’ Ratings Updates for Fate Therapeutics $FATE https://t.co/QNTbGn2wjZ #stocks
August 9th 2018, 11:08am
ZolmaxNews @ZolmaxNews
Weekly Analysts’ Ratings Updates for Fate Therapeutics $FATE https://t.co/Tp1STzVVQu
August 9th 2018, 11:08am
bbnsnews @bbnsnews
Fate Therapeutics $FATE Raised to “Hold” at Zacks Investment Research https://t.co/E7ERYRG54c
August 9th 2018, 9:08am
TickerReport @TickerReport
HC Wainwright Reiterates “Hold” Rating for Fate Therapeutics $FATE https://t.co/Pws0Wdn6FP
August 9th 2018, 1:08am
dailypoliticaln @dailypoliticaln
HC Wainwright Reiterates “Hold” Rating for Fate Therapeutics $FATE https://t.co/KKF7O0E8ie
August 9th 2018, 1:08am
TickerReport @TickerReport
HC Wainwright Reiterates “Hold” Rating for Fate Therapeutics $FATE https://t.co/B7Q4yLMEnT
August 9th 2018, 1:08am
dailypoliticaln @dailypoliticaln
HC Wainwright Reiterates “Hold” Rating for Fate Therapeutics $FATE https://t.co/vn4zZgWYrf
August 9th 2018, 1:08am
WatchlistN @WatchlistN
Fate Therapeutics Inc to Post FY2018 Earnings of -$1.25 Per Share, Piper Jaffray Companies Forecasts $FATE https://t.co/cGmagobrSB
August 9th 2018, 12:08am
MareaInformativ @MareaInformativ
Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Fate Therapeutics $FATE Share Price https://t.co/7AZR22WWmU
August 8th 2018, 11:08pm
dispatchtribune @dispatchtribune
Fate Therapeutics $FATE Issues Earnings Results https://t.co/qwMXQuuuIK
August 8th 2018, 8:08pm
Slambucket @Slambucket
$FATE seems to have some sort of immunity to this small cap bio degenerative disease
August 8th 2018, 6:08pm
OlympiaReport @OlympiaReport
Fate Therapeutics $FATE Receives Outperform Rating from Wedbush https://t.co/h3RixpQH1P
August 8th 2018, 6:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.